Table 2 Lesion characteristics and bronchoscopy data
From: Safety and efficacy of transbronchial cryobiopsy for elderly lung cancer patients
Elderly (≥ 80) (n = 20) | Younger (< 80) (n = 76) | p value* | |||
|---|---|---|---|---|---|
Lesion size, median (range), mm | 29.7 (15.8-140.3) | 31.5 (10.9-102.9) | 0.729** | ||
Lobar location, n (%) | 0.730† | ||||
Upper | 10 (50) | 30 (39.5) | |||
Middle/Lingular | 2 (10) | 10 (13.2) | |||
Lower | 8 (40) | 36 (47.3) | |||
Diameter of the Cryoprobe, n (%) | 0.834 | ||||
1.1 mm | 14 (70) | 55 (72.4) | |||
1.7 /1.9 mm | 6 (30) | 21 (27.6) | |||
Number of cryobiopsy specimens, median (range) | 3 (1–4) | 3 (1–4) | 0.527* | ||
Procedures, n (%) | 0.850 | ||||
Cryobiopsy alone | 11 (55) | 40 (52.7) | |||
Combined with forceps biopsy | 9 (45) | 36 (47.3) | |||
Sedation, n (%) | 0.001 | ||||
Midazolam and pethidine | 15 (75) | 26 (34.2) | |||
Midazolam, pethidine and dexmedetomidine | 5 (25) | 50 (65.8) | |||
Dose of midazolam, mean (SD), mg | 7.41 | 8.23 | 0.267‡ | ||
Dose of lidocaine, mean (SD), mg | 398.5 | 413.6 | 0.452‡ | ||